Health Sciences

PHILADELPHIA — The National Institutes of Health's National Heart, Lung, and Blood Institute (NHLBI) awarded $18.5 million to establish the Personalized NSAID Therapeutics Consortium (PENTACON), an international group of scientists led by Garret A.

PHILADELPHIA — In an alliance aimed at bringing a new, personalized immunotherapy approach to patients with a wide variety of cancers, the University of Pennsylvania and Novartis announced today an exclusive global research and licensing agreement to further study and commercialize novel cellular immunotherapies using chimeric antigen receptor (CAR) technologies.

The Department of Health and Human Services has selected the Hospital of the University of Pennsylvania (HUP) as one of five hospitals that will take part in a nationwide initiative designed to train more nurses at a higher level.

A new risk management plan from the U.S. Food and Drug Administration to help clinicians properly prescribe drugs with addiction potential aims to help reduce the growing epidemic of opioid abuse in the United States.

PHILADELPHIA — Two University of Pennsylvania professors have been named winners of Presidential Early Career Awards for Scientists and Engineers.

PHILADELPHIA — Human diversity in Africa is greater than any place else on Earth. Differing food sources, geographies, diseases and climates offered many targets for natural selection to exert powerful forces on Africans to change and adapt to their local environments.

Pennsylvania Hospital (PAH) has been selected to participate in Best Fed Beginnings, a first-of-its-kind national effort to significantly improve breastfeeding rates in states where rates are currently the lowest.

The percentage of HIV patients taking antiretroviral drugs who experienced the full benefit of the drugs jumped from 45 percent of 72 percent during the past decade, a figure that is lower than previous estimates.

While clinical trial results are being released regarding drugs intended to decrease amyloid production - thought to contribute to decline in Alzheimer's disease - clinical trials of drugs targeting other disease proteins, such as tau, are in their initial phases.

  Penn Nursing students spend many hours in the classroom, but their curriculum also provides hands-on instruction, through simulation education.